A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

NCT03792152 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Left Atrial Appendage Thrombosis
Rivaroxaban

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin

Sponsor

The Second Affiliated Hospital of Chongqing Medical University